2022
Antiplatelet regimens following carotid artery revascularization
Lee M, Ahmed ZV, Huang J, Brice A, Arham A, Castro-Dominguez Y, Aboian E, Nagpal S, Smolderen KG, Mena-Hurtado C. Antiplatelet regimens following carotid artery revascularization. American Heart Journal 2022, 253: 48-52. PMID: 35863439, DOI: 10.1016/j.ahj.2022.07.004.Peer-Reviewed Original ResearchMeSH KeywordsCarotid ArteriesCarotid StenosisEndarterectomy, CarotidHumansPlatelet Aggregation InhibitorsRetrospective StudiesRisk FactorsStentsStrokeTreatment OutcomeConceptsDual antiplatelet therapySingle antiplatelet therapyCarotid artery stentingCarotid endarterectomyAntiplatelet therapyReal-world clinical practiceCarotid artery revascularizationLow adherence ratesArtery revascularizationArtery stentingAdherence ratesClinical practicePatientsTherapyEngland dataHigh percentageRevascularizationAntiplateletEndarterectomyStenting
2013
Carotid Revascularization: A Systematic Review of the Evidence
AL‐DAMLUJI M, NAGPAL S, STILP E, REMETZ M, MENA C. Carotid Revascularization: A Systematic Review of the Evidence. Journal Of Interventional Cardiology 2013, 26: 399-410. PMID: 23844747, DOI: 10.1111/joic.12037.Peer-Reviewed Original ResearchConceptsCarotid artery stentingProspective clinical trialsHigh surgical risk patientsSurgical risk patientsEmbolic protection devicesCarotid endarterectomyClinical trialsRisk patientsMyocardial infarctionIncidence rateSafety of CASEffective stroke prevention strategiesHigh surgical risk candidatesLong-term outcome ratesObjective performance criteriaTrials (RCTs) comparing outcomesHigh surgical riskStroke prevention strategiesEvidence-based reviewPatient selection strategiesLong-term effectivenessArtery stentingPeriprocedural safetySurgical riskComparing outcomes